EVI1-a novel oncogene in prostate carcinoma

被引:0
|
作者
Wang, H. [1 ,2 ]
Queisser, A. [3 ]
Hagedorn, S. [3 ]
Konantz, M. [1 ]
Schaefer, T. [1 ]
Alavi, S. [3 ]
Vogel, W. [4 ,5 ]
Maessenhausen, A., V [3 ]
Kristiansen, G. [3 ]
Duensing, S. [6 ]
Kirfel, J. [3 ]
Perner, S. [4 ,5 ]
Lengerke, C. [1 ,2 ,7 ]
机构
[1] Univ Basel Hosp, Dept Biomed, Basel, Switzerland
[2] Univ Tubingen, Med Ctr 2, Dept Hematol & Oncol, Tubingen, Germany
[3] Univ Hosp Bonn, Sect Prostate Canc Res, Inst Pathol, Ctr Integrated Oncol Cologne Bonn, Bonn, Germany
[4] Univ Hosp Luebeck, Pathol, Lubeck, Germany
[5] Leibniz Res Ctr Borstel, Borstel, Germany
[6] Heidelberg Univ, Sch Med, Sect Mol Urooncol, Dept Urol, Heidelberg, Germany
[7] Univ Basel Hosp, Clin Hematol, Basel, Switzerland
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P884
引用
收藏
页码:267 / 267
页数:1
相关论文
共 50 条
  • [21] Prominent Oncogenic Roles of EVI1 in Breast Carcinoma
    Wang, Hui
    Schaefer, Thorsten
    Konantz, Martina
    Braun, Martin
    Varga, Zsuzsanna
    Paczulla, Anna M.
    Reich, Selina
    Jacob, Francis
    Perner, Sven
    Moch, Holger
    Fehm, Tanja N.
    Kanz, Lothar
    Schulze-Osthoff, Klaus
    Lengerke, Claudia
    CANCER RESEARCH, 2017, 77 (08) : 2148 - 2160
  • [22] The Evi-1 proto-oncogene encodes a transcriptional repressor activity associated with transformation
    Chris Bartholomew
    Anna Kilbey
    Anne-Marie Clark
    Mark Walker
    Oncogene, 1997, 14 : 569 - 577
  • [23] The Evi-1 proto-oncogene encodes a transcriptional repressor activity associated with transformation
    Bartholomew, C
    Kilbey, A
    Clark, AM
    Walker, M
    ONCOGENE, 1997, 14 (05) : 569 - 577
  • [24] The transcription factor LSF: a novel oncogene for hepatocellular carcinoma
    Santhekadur, Prasanna K.
    Rajasekaran, Devaraja
    Siddiq, Ayesha
    Gredler, Rachel
    Chen, Dong
    Schaus, Scott E.
    Hansen, Ulla
    Fisher, Paul B.
    Sarkar, Devanand
    AMERICAN JOURNAL OF CANCER RESEARCH, 2012, 2 (03): : 269 - 285
  • [25] FoxF1 is a potential oncogene in prostate cancer
    Nowak, M.
    Menon, R.
    Kunze, F. A.
    Svensson, M. A.
    Carlsson, J.
    Wernert, N.
    Kristiansen, G.
    Andren, O.
    Perner, S.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S37 - S37
  • [26] RETRACTED: EVI-1 acts as an oncogene and positively regulates calreticulin in breast cancer (Retracted Article)
    Wu, Lei
    Wang, Tianyi
    He, Dongning
    Li, Xiaoxi
    Jiang, Youhong
    MOLECULAR MEDICINE REPORTS, 2019, 19 (03) : 1645 - 1653
  • [27] FoxF1 is a potential oncogene in prostate cancer
    Bossmann, Carolin
    Merz, Constanze
    Tolkach, Yuri
    Carlsson, Jessica
    Perner, Sven
    Andren, Ove
    Kristiansen, Glen
    Nowak, Michael
    CANCER RESEARCH, 2017, 77
  • [28] The regulatory interaction of EVI1 with the TCL1A oncogene impacts cell survival and clinical outcome in CLL
    E Vasyutina
    J M Boucas
    J Bloehdorn
    C Aszyk
    G Crispatzu
    M Stiefelhagen
    A Breuer
    P Mayer
    C Lengerke
    H Döhner
    D Beutner
    A Rosenwald
    S Stilgenbauer
    M Hallek
    A Benner
    M Herling
    Leukemia, 2015, 29 : 2003 - 2014
  • [29] Human prostatic carcinoma oncogene PTI-1 is expressed in human tumor cell lines and prostate carcinoma patient blood samples
    Sun, YL
    Lin, J
    Katz, AE
    Fisher, PB
    CANCER RESEARCH, 1997, 57 (01) : 18 - 23
  • [30] New functions for ecotropic viral integration site 1 (EVI1), an oncogene causing aggressive malignant disease
    Wieser, Rotraud
    CELL CYCLE, 2012, 11 (21) : 3915 - 3915